Reply to: Experimental aspects of copy number variant assays at CCL3L1

Autores: He, Weijing; Kulkarni, Hemant; Castiblanco, John; Shimizu, Chisato; Aluyen, Una; Maldonado, Robert; Carrillo, Andrew; Griffin, Madeline; Lipsitt, Amanda; Beachy, Lisa; Shostakovich-Koretskaya, Ludmila; Mangano, Andrea María Mercedes; Sen, Luisa; Nibbs, Robert J. B.; Tiemessen, Caroline T.; Bolivar, Hector; Bamshad, Michael J.; Clark, Robert A.; Burns, Jane C.; Dolan, Matthew J.; Ahuja, Sunil K.
Año de publicación: 2009
Idioma: inglés
Tipo de recurso: artículo
Estado: versión publicada
Descripción: We read with interest the recent article in Nature Medicine describingthe influence of variation in CCL3L1 copy number and CCR5 genotypeon immune recovery during highly active antiretroviral therapy (HAART) in HIV-1?infected individuals1. The chemotactic cytokine CCL3L1 (encoding the macrophage inflammatory protein-1αP (MIP-1αP) protein) is a potent ligand for the HIV-1 co-receptor CCR5, whichis essential for viral entry into human host cells2. The recent study is part of a series that began in 2005 with a paper reporting effects of CCL3L1 copy number variation on HIV-1 acquisition, viral load and disease progression3, followed by several publications investigating clinicallycorrelated phenotypes in a largely overlapping set of HIV-positive individuals1,4,5.
Fil: He, Weijing. South Texas Veterans Health Care System; Estados Unidos. University Of Texas Health Science Center At San Antonio; Estados Unidos
Fil: Kulkarni, Hemant. University Of Texas Health Science Center At San Antonio; Estados Unidos. South Texas Veterans Health Care System; Estados Unidos
Fil: Castiblanco, John. South Texas Veterans Health Care System; Estados Unidos. University Of Texas Health Science Center At San Antonio; Estados Unidos
Fil: Shimizu, Chisato. University of California at San Diego; Estados Unidos
Fil: Aluyen, Una. South Texas Veterans Health Care System; Estados Unidos. University Of Texas Health Science Center At San Antonio; Estados Unidos
Fil: Maldonado, Robert. University Of Texas Health Science Center At San Antonio; Estados Unidos. South Texas Veterans Health Care System; Estados Unidos
Fil: Carrillo, Andrew. South Texas Veterans Health Care System; Estados Unidos. University Of Texas Health Science Center At San Antonio; Estados Unidos
Fil: Griffin, Madeline. South Texas Veterans Health Care System; Estados Unidos. University Of Texas Health Science Center At San Antonio; Estados Unidos
Fil: Lipsitt, Amanda. South Texas Veterans Health Care System; Estados Unidos. University Of Texas Health Science Center At San Antonio; Estados Unidos
Fil: Beachy, Lisa. South Texas Veterans Health Care System; Estados Unidos. University Of Texas Health Science Center At San Antonio; Estados Unidos
Fil: Shostakovich-Koretskaya, Ludmila. State Establishment Dnipropetrovsk Medical Academy Of Health Ministry Of Ukraine; Ucrania
Fil: Mangano, Andrea María Mercedes. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Sen, Luisa. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina
Fil: Nibbs, Robert J. B.. University of Glasgow; Reino Unido
Fil: Tiemessen, Caroline T.. University of the Witwatersrand; Sudáfrica
Fil: Bolivar, Hector. University of Miami; Estados Unidos
Fil: Bamshad, Michael J.. Washington State University; Estados Unidos
Fil: Clark, Robert A.. University Of Texas Health Science Center At San Antonio; Estados Unidos. South Texas Veterans Health Care System; Estados Unidos
Fil: Burns, Jane C.. University of California at San Diego; Estados Unidos
Fil: Dolan, Matthew J.. San Antonio Military Medical Center; Estados Unidos. Lackland Air Force Base; Estados Unidos
Fil: Ahuja, Sunil K.. South Texas Veterans Health Care System; Estados Unidos. University Of Texas Health Science Center At San Antonio; Estados Unidos
Materia: copy number variants
ccl3l1
Nivel de accesibilidad: acceso abierto
Condiciones de uso: https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
Institución: Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador: oai:ri.conicet.gov.ar:11336/96241

Acceder

id	CONICETDig_a0a32dd71eba3d6e9e2b6d4798c91fe5
oai_identifier_str	oai:ri.conicet.gov.ar:11336/96241
network_acronym_str	CONICETDig
repository_id_str	3498
network_name_str	CONICET Digital (CONICET)
spelling	Reply to: Experimental aspects of copy number variant assays at CCL3L1He, WeijingKulkarni, HemantCastiblanco, JohnShimizu, ChisatoAluyen, UnaMaldonado, RobertCarrillo, AndrewGriffin, MadelineLipsitt, AmandaBeachy, LisaShostakovich-Koretskaya, LudmilaMangano, Andrea María MercedesSen, LuisaNibbs, Robert J. B.Tiemessen, Caroline T.Bolivar, HectorBamshad, Michael J.Clark, Robert A.Burns, Jane C.Dolan, Matthew J.Ahuja, Sunil K.copy number variantsccl3l1https://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1We read with interest the recent article in Nature Medicine describingthe influence of variation in CCL3L1 copy number and CCR5 genotypeon immune recovery during highly active antiretroviral therapy (HAART) in HIV-1?infected individuals1. The chemotactic cytokine CCL3L1 (encoding the macrophage inflammatory protein-1αP (MIP-1αP) protein) is a potent ligand for the HIV-1 co-receptor CCR5, whichis essential for viral entry into human host cells2. The recent study is part of a series that began in 2005 with a paper reporting effects of CCL3L1 copy number variation on HIV-1 acquisition, viral load and disease progression3, followed by several publications investigating clinicallycorrelated phenotypes in a largely overlapping set of HIV-positive individuals1,4,5.Fil: He, Weijing. South Texas Veterans Health Care System; Estados Unidos. University Of Texas Health Science Center At San Antonio; Estados UnidosFil: Kulkarni, Hemant. University Of Texas Health Science Center At San Antonio; Estados Unidos. South Texas Veterans Health Care System; Estados UnidosFil: Castiblanco, John. South Texas Veterans Health Care System; Estados Unidos. University Of Texas Health Science Center At San Antonio; Estados UnidosFil: Shimizu, Chisato. University of California at San Diego; Estados UnidosFil: Aluyen, Una. South Texas Veterans Health Care System; Estados Unidos. University Of Texas Health Science Center At San Antonio; Estados UnidosFil: Maldonado, Robert. University Of Texas Health Science Center At San Antonio; Estados Unidos. South Texas Veterans Health Care System; Estados UnidosFil: Carrillo, Andrew. South Texas Veterans Health Care System; Estados Unidos. University Of Texas Health Science Center At San Antonio; Estados UnidosFil: Griffin, Madeline. South Texas Veterans Health Care System; Estados Unidos. University Of Texas Health Science Center At San Antonio; Estados UnidosFil: Lipsitt, Amanda. South Texas Veterans Health Care System; Estados Unidos. University Of Texas Health Science Center At San Antonio; Estados UnidosFil: Beachy, Lisa. South Texas Veterans Health Care System; Estados Unidos. University Of Texas Health Science Center At San Antonio; Estados UnidosFil: Shostakovich-Koretskaya, Ludmila. State Establishment Dnipropetrovsk Medical Academy Of Health Ministry Of Ukraine; UcraniaFil: Mangano, Andrea María Mercedes. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Sen, Luisa. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; ArgentinaFil: Nibbs, Robert J. B.. University of Glasgow; Reino UnidoFil: Tiemessen, Caroline T.. University of the Witwatersrand; SudáfricaFil: Bolivar, Hector. University of Miami; Estados UnidosFil: Bamshad, Michael J.. Washington State University; Estados UnidosFil: Clark, Robert A.. University Of Texas Health Science Center At San Antonio; Estados Unidos. South Texas Veterans Health Care System; Estados UnidosFil: Burns, Jane C.. University of California at San Diego; Estados UnidosFil: Dolan, Matthew J.. San Antonio Military Medical Center; Estados Unidos. Lackland Air Force Base; Estados UnidosFil: Ahuja, Sunil K.. South Texas Veterans Health Care System; Estados Unidos. University Of Texas Health Science Center At San Antonio; Estados UnidosNature Publishing Group2009-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/96241He, Weijing; Kulkarni, Hemant; Castiblanco, John; Shimizu, Chisato; Aluyen, Una; et al.; Reply to: Experimental aspects of copy number variant assays at CCL3L1; Nature Publishing Group; Nature Medicine; 15; 10; 10-2009; 1117-11201078-8956CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.nature.com/articles/nm1009-1117info:eu-repo/semantics/altIdentifier/doi/10.1038/nm1009-1117info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:03:44Zoai:ri.conicet.gov.ar:11336/96241instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:03:45.22CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv	Reply to: Experimental aspects of copy number variant assays at CCL3L1
title	Reply to: Experimental aspects of copy number variant assays at CCL3L1
spellingShingle	Reply to: Experimental aspects of copy number variant assays at CCL3L1 He, Weijing copy number variants ccl3l1
title_short	Reply to: Experimental aspects of copy number variant assays at CCL3L1
title_full	Reply to: Experimental aspects of copy number variant assays at CCL3L1
title_fullStr	Reply to: Experimental aspects of copy number variant assays at CCL3L1
title_full_unstemmed	Reply to: Experimental aspects of copy number variant assays at CCL3L1
title_sort	Reply to: Experimental aspects of copy number variant assays at CCL3L1
dc.creator.none.fl_str_mv	He, Weijing Kulkarni, Hemant Castiblanco, John Shimizu, Chisato Aluyen, Una Maldonado, Robert Carrillo, Andrew Griffin, Madeline Lipsitt, Amanda Beachy, Lisa Shostakovich-Koretskaya, Ludmila Mangano, Andrea María Mercedes Sen, Luisa Nibbs, Robert J. B. Tiemessen, Caroline T. Bolivar, Hector Bamshad, Michael J. Clark, Robert A. Burns, Jane C. Dolan, Matthew J. Ahuja, Sunil K.
author	He, Weijing
author_facet	He, Weijing Kulkarni, Hemant Castiblanco, John Shimizu, Chisato Aluyen, Una Maldonado, Robert Carrillo, Andrew Griffin, Madeline Lipsitt, Amanda Beachy, Lisa Shostakovich-Koretskaya, Ludmila Mangano, Andrea María Mercedes Sen, Luisa Nibbs, Robert J. B. Tiemessen, Caroline T. Bolivar, Hector Bamshad, Michael J. Clark, Robert A. Burns, Jane C. Dolan, Matthew J. Ahuja, Sunil K.
author_role	author
author2	Kulkarni, Hemant Castiblanco, John Shimizu, Chisato Aluyen, Una Maldonado, Robert Carrillo, Andrew Griffin, Madeline Lipsitt, Amanda Beachy, Lisa Shostakovich-Koretskaya, Ludmila Mangano, Andrea María Mercedes Sen, Luisa Nibbs, Robert J. B. Tiemessen, Caroline T. Bolivar, Hector Bamshad, Michael J. Clark, Robert A. Burns, Jane C. Dolan, Matthew J. Ahuja, Sunil K.
author2_role	author author author author author author author author author author author author author author author author author author author author
dc.subject.none.fl_str_mv	copy number variants ccl3l1
topic	copy number variants ccl3l1
purl_subject.fl_str_mv	https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv	We read with interest the recent article in Nature Medicine describingthe influence of variation in CCL3L1 copy number and CCR5 genotypeon immune recovery during highly active antiretroviral therapy (HAART) in HIV-1?infected individuals1. The chemotactic cytokine CCL3L1 (encoding the macrophage inflammatory protein-1αP (MIP-1αP) protein) is a potent ligand for the HIV-1 co-receptor CCR5, whichis essential for viral entry into human host cells2. The recent study is part of a series that began in 2005 with a paper reporting effects of CCL3L1 copy number variation on HIV-1 acquisition, viral load and disease progression3, followed by several publications investigating clinicallycorrelated phenotypes in a largely overlapping set of HIV-positive individuals1,4,5. Fil: He, Weijing. South Texas Veterans Health Care System; Estados Unidos. University Of Texas Health Science Center At San Antonio; Estados Unidos Fil: Kulkarni, Hemant. University Of Texas Health Science Center At San Antonio; Estados Unidos. South Texas Veterans Health Care System; Estados Unidos Fil: Castiblanco, John. South Texas Veterans Health Care System; Estados Unidos. University Of Texas Health Science Center At San Antonio; Estados Unidos Fil: Shimizu, Chisato. University of California at San Diego; Estados Unidos Fil: Aluyen, Una. South Texas Veterans Health Care System; Estados Unidos. University Of Texas Health Science Center At San Antonio; Estados Unidos Fil: Maldonado, Robert. University Of Texas Health Science Center At San Antonio; Estados Unidos. South Texas Veterans Health Care System; Estados Unidos Fil: Carrillo, Andrew. South Texas Veterans Health Care System; Estados Unidos. University Of Texas Health Science Center At San Antonio; Estados Unidos Fil: Griffin, Madeline. South Texas Veterans Health Care System; Estados Unidos. University Of Texas Health Science Center At San Antonio; Estados Unidos Fil: Lipsitt, Amanda. South Texas Veterans Health Care System; Estados Unidos. University Of Texas Health Science Center At San Antonio; Estados Unidos Fil: Beachy, Lisa. South Texas Veterans Health Care System; Estados Unidos. University Of Texas Health Science Center At San Antonio; Estados Unidos Fil: Shostakovich-Koretskaya, Ludmila. State Establishment Dnipropetrovsk Medical Academy Of Health Ministry Of Ukraine; Ucrania Fil: Mangano, Andrea María Mercedes. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Sen, Luisa. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina Fil: Nibbs, Robert J. B.. University of Glasgow; Reino Unido Fil: Tiemessen, Caroline T.. University of the Witwatersrand; Sudáfrica Fil: Bolivar, Hector. University of Miami; Estados Unidos Fil: Bamshad, Michael J.. Washington State University; Estados Unidos Fil: Clark, Robert A.. University Of Texas Health Science Center At San Antonio; Estados Unidos. South Texas Veterans Health Care System; Estados Unidos Fil: Burns, Jane C.. University of California at San Diego; Estados Unidos Fil: Dolan, Matthew J.. San Antonio Military Medical Center; Estados Unidos. Lackland Air Force Base; Estados Unidos Fil: Ahuja, Sunil K.. South Texas Veterans Health Care System; Estados Unidos. University Of Texas Health Science Center At San Antonio; Estados Unidos
description	We read with interest the recent article in Nature Medicine describingthe influence of variation in CCL3L1 copy number and CCR5 genotypeon immune recovery during highly active antiretroviral therapy (HAART) in HIV-1?infected individuals1. The chemotactic cytokine CCL3L1 (encoding the macrophage inflammatory protein-1αP (MIP-1αP) protein) is a potent ligand for the HIV-1 co-receptor CCR5, whichis essential for viral entry into human host cells2. The recent study is part of a series that began in 2005 with a paper reporting effects of CCL3L1 copy number variation on HIV-1 acquisition, viral load and disease progression3, followed by several publications investigating clinicallycorrelated phenotypes in a largely overlapping set of HIV-positive individuals1,4,5.
publishDate	2009
dc.date.none.fl_str_mv	2009-10
dc.type.none.fl_str_mv	info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo
format	article
status_str	publishedVersion
dc.identifier.none.fl_str_mv	http://hdl.handle.net/11336/96241 He, Weijing; Kulkarni, Hemant; Castiblanco, John; Shimizu, Chisato; Aluyen, Una; et al.; Reply to: Experimental aspects of copy number variant assays at CCL3L1; Nature Publishing Group; Nature Medicine; 15; 10; 10-2009; 1117-1120 1078-8956 CONICET Digital CONICET
url	http://hdl.handle.net/11336/96241
identifier_str_mv	He, Weijing; Kulkarni, Hemant; Castiblanco, John; Shimizu, Chisato; Aluyen, Una; et al.; Reply to: Experimental aspects of copy number variant assays at CCL3L1; Nature Publishing Group; Nature Medicine; 15; 10; 10-2009; 1117-1120 1078-8956 CONICET Digital CONICET
dc.language.none.fl_str_mv	eng
language	eng
dc.relation.none.fl_str_mv	info:eu-repo/semantics/altIdentifier/url/https://www.nature.com/articles/nm1009-1117 info:eu-repo/semantics/altIdentifier/doi/10.1038/nm1009-1117
dc.rights.none.fl_str_mv	info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv	openAccess
rights_invalid_str_mv	https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv	application/pdf application/pdf
dc.publisher.none.fl_str_mv	Nature Publishing Group
publisher.none.fl_str_mv	Nature Publishing Group
dc.source.none.fl_str_mv	reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str	CONICET Digital (CONICET)
collection	CONICET Digital (CONICET)
instname_str	Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv	CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv	dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_	1842269817802850304
score	13.13397

Reply to: Experimental aspects of copy number variant assays at CCL3L1

Publicaciones similares